Breast Neoplasms
Conditions
Interventions
None listed
Sponsors
Akashi Sadako
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Eligibility is limited to patients who meet both of the following criteria: 1.Female patients diagnosed with primary breast cancer prior to the start of treatment 2.Patients who have provided informed consent to participate in this trial Eligibility is limited to those who meet either criteria 1 and 3 or criteria 2 and 3 below. 1.Women who visited a clinic for breast cancer screening 2.Female patients who were informed of a possible breast cancer diagnosis and visited a clinic for further evaluation 3.Patients who have provided informed consent to participate in this trial
Exclusion criteria
Exclusion criteria: 1.Patients under the age of 18 2.Patients with a history of breast cancer treatment prior to enrollment in this trial 3.Patients in whom a needle biopsy cannot be performed 4.Patients currently taking oral hypoglycemic agents (metformin hydrochloride) 5.Other patients deemed unsuitable for inclusion in the study by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity and Specificity of Breast Cancer Diagnosis Using Volatile Organic Compounds in Exhaled Breath | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Positive predictive value (PPV) and negative predictive value (NPV) of volatile organic compounds in exhaled breath for breast cancer diagnosis 2.Correlation between volatile organic compounds in exhaled breath and histopathological diagnosis 3.Correlation between volatile organic compounds in exhaled breath and disease stage | — |
Contacts
Public ContactHiroko Tsukada
Tokyo Women's Medical University Hospital
Outcome results
None listed